Anzeige
Mehr »
Login
Freitag, 25.04.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Vergiss die Indizes - Forge steigt um 40 %, während der S&P & Dow fällt!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40HQP | ISIN: US74933X6094 | Ticker-Symbol: 4RM0
NASDAQ
24.04.25
17:24 Uhr
0,329 US-Dollar
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CATHETER PRECISION INC Chart 1 Jahr
5-Tage-Chart
CATHETER PRECISION INC 5-Tage-Chart

Aktuelle News zur CATHETER PRECISION Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiCatheter Precision to acquire late-stage heart failure treatment assets in development1
CATHETER PRECISION Aktie jetzt für 0€ handeln
17.04.Catheter Precision, Inc.: Catheter Precision Makes NYSE American Section 610(b) Public Announcement1
16.04.Catheter Precision, Inc. - 8-K, Current Report1
01.04.Catheter Precision, Inc. - 8-K, Current Report4
28.03.Catheter Precision, Inc. Announces Fourth Quarter and Full Year 2024 Update and Financial Results244FORT MILL, S.C., March 28, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced...
► Artikel lesen
12.03.Catheter Precision, Inc. - 8-K, Current Report2
06.02.Catheter Precision, Inc.: Catheter Precision to Attend and Participate in the 13th Internation Symposium on Left Atrial Appendage3
04.02.Catheter Precision, Inc. - 8-K, Current Report-
04.02.Catheter Precision, Inc. Announces The Closing of its Acquisition of PeriKard, LLC1
17.01.Catheter Precision, Inc. - 8-K, Current Report-
16.01.Catheter Precision, Inc: Catheter Precision to Attend the 30th International Atrial Fibrillation Symposium208FORT MILL, SOUTH CAROLINA / ACCESS Newswire / January 16, 2025 / Catheter Precision, Inc. (NYSE American:VTAK), a US based medical device company focused on developing technologically advanced products...
► Artikel lesen
15.01.Catheter Precision, Inc. Announces Definitive Agreement to Acquire PeriKard, LLC190FORT MILL, SC / ACCESSWIRE / January 15, 2025 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced that...
► Artikel lesen
13.01.Catheter Precision, Inc. Announces Initial LockeT Purchase From the University of Tennessee Medical Center259FORT MILL, SC / ACCESSWIRE / January 13, 2025 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced it...
► Artikel lesen
07.01.Catheter Precision, Inc. - 8-K, Current Report-
07.01.Catheter Precision names new CFO1
07.01.Catheter Precision, Inc. Announces New Chief Financial Officer235FORT MILL, SC / ACCESSWIRE / January 7, 2025 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced that...
► Artikel lesen
21.11.24Catheter Precision, Inc. - S-1, General form for registration of securities1
14.11.24Catheter Precision, Inc. Announces Initial LockeT Purchase From Montefiore Medical Center352FORT MILL, SC / ACCESSWIRE / November 14, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced...
► Artikel lesen
13.11.24Ra Medical Systems reports Q3 results5
13.11.24Catheter Precision, Inc. Announces Third Quarter Update and Financial Results218FORT MILL, SC / ACCESSWIRE / November 13, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced...
► Artikel lesen
Seite:  Weiter >>
51 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1